|

SHR-8068 Injection Clinical Trials

4 actively recruiting trials

Pipeline

Phase 2: 2Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Suzhou Suncadia Biopharmaceuticals Co., Ltd.3
  • Shanghai Hengrui Pharmaceutical Co., Ltd.1

Indications

  • Cancer4
  • Advanced Urothelial Carcinoma1
  • Advanced Biliary Tract Cancer1
  • Colorectal Cancer1
  • Gastric Cancer1

Other4 trials

A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
Phase 2
A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)
Phase 3
A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer
Phase 2
A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.